Fasting during chemo: a new way to ease side effects?
NCT ID NCT06645093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether fasting for 24 hours before and after chemotherapy is safe and doable for people with Hodgkin or Diffuse Large B Cell Lymphoma. 40 participants will either fast or follow standard care, tracking side effects, diet, and quality of life. The goal is to see if a larger trial is possible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fasting (water-only for 24 hours before and after chemotherapy)
- What this could lead to
- If it works, this could show that fasting is a safe and tolerable way to potentially reduce side effects during lymphoma chemotherapy.
- What could go wrong
- This is a very small feasibility trial with only 40 people, so results may not apply broadly. Fasting may be hard to stick with and could cause weight loss or other issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Nutrition, University of Oslo
Oslo, Oslo, 0372, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Could muscle loss predict blood cancer outcomes?
- Could sitting up make radiation therapy more comfortable?
- Can an immune booster outsmart brain lymphoma?
- Can we predict dangerous side effects when combining radiation and immunotherapy?